首页 | 本学科首页   官方微博 | 高级检索  
     


Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Authors:Carla Abdelnour MD  Inger van Steenoven MSc  Elisabet Londos MD  PhD  Frédéric Blanc MD  PhD  Bj?rn Auestad PhD  Milica G. Kramberger MD  PhD  Henrik Zetterberg MD  PhD  Brit Mollenhauer MD  Mercè Boada MD  PhD
Affiliation:1. Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona, Spain;2. Alzheimer Center, Department of Neurology, VU Medical Center, Amsterdam, The Netherlands;3. Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm?, Sweden;4. Neuropsychology Unit and Geriatric Day Hospital (Strasbourg Resource and Research Memory Center, CMRR), University Hospital of Strasbourg and ICube laboratory, FMTS, University of Strasbourg and CNRS, Strasbourg, France;5. Research Department, Stavanger University Hospital, Stavanger, Norway;6. Department of Mathematics and Natural Sciences, University of Stavanger, Stavanger, Norway;7. Department of Neurology, University Medical Center, Ljubljana, Slovenia;8. Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M?lndal, Sweden;9. Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom;10. Paracelsus‐Elena‐Klinik, Kassel and University Medical Center, Department of Neurosurgery and Institute of Neuropathology, G?ttingen, Germany
Abstract:
Keywords:Lewy body dementia  CSF biomarkers  cognitive decline
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号